The 10 Biggest Clinical Success Stories of 2016 in European Biotech
What are the most impressive advances in medical biotechnology this year? From cancer to peanut…
22/12/2016 - 5 minutes
Cellectis
What do the CAR-T Patient Deaths Mean for the Future of the Field?
Juno’s JCAR015 study came to a halt for the second time this year after two…
14/12/2016 - 7 minutes
Would you Taste this Gene-Edited Dinner?
Genetic engineering can make food healthier, improve nutrition and reduce environmental impact. To demonstrate its…
05/11/2016 - 2 minutes
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
CAR-T therapies have gained plenty of attention lately by promising to end cancer with a one-off…
29/09/2016 - 5 minutes
UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study
A CAR-T program in Phase II trials (from Juno Therapeutics) was suspended by the FDA…
18/07/2016 - 5 minutes
Cellectis gets paid for a first Milestone, Investors are pleased
After successfully 'saving' two babies with terminal-stage acute Leukemia, Cellectis finally treated the first patient…
23/06/2016 - 2 minutes
It’s Blood Cancer Day, how is Biotech fixing it?
Today is the World Blood Cancer Day, an event to show solidarity to patients and…
28/05/2016 - 4 minutes
How Good was 2015 for the French Universal CAR-T Biotech?
Cellectis (France) has now released its financial results for 2015. What happened and what the…
16/03/2016 - 3 minutes
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more…
23/02/2016 - 6 minutes
Cancer: World Best Ever CAR-T Results have Just been Disclosed
These are the best results yet for CAR-T, this time from a research group led by…
17/02/2016 - 3 minutes
The European Union Finances the Future of CAR-T Manufacturing
CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes…
08/02/2016 - 3 minutes
2011-2015: What a Fantastic 5 Years for European Biotech
The crisis of 2008 hit the Biotech sector hard, and it wasn't clear how the…
26/01/2016 - 5 minutes
